Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEASURE: MRI Evaluation in SLE Arthritis
NCT03355482Phase 2Terminated
- Sponsor
- Oklahoma Medical Research Foundation
- Start
- Apr 2017
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in systemic lupus erythematosus (SLE), sponsored by Oklahoma Medical Research Foundation. Started Apr 2017; status: terminated.
02
Drugs
methylprednisolone injection
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03355482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355482.